Matt Bennett

Director at Real Chemistry

Matt Bennett, Managing Director, joined New Mountain as an operating partner in 2016 and has worked as an executive in NMC companies continuously since 2007. He serves on the Boards of CIOX Health, Gelest, Cytel, Sparta Systems, and Bellerophon Therapeutics and works closely with other NMC companies.

Matt was previously CEO of CIOX Health. Before that, he was Executive Vice President, Global Medical Operations and Chief Legal Officer for Ikaria, Inc., where he served in additional executive roles, including Chief Financial Officer and head of Corporate Development. Prior to joining Ikaria, Matt was Executive Vice President, Chief Administrative Officer, and Chief Business Officer at VIASYS Healthcare, Inc. (NYSE: VAS), where he was responsible for the company’s growth and mergers and acquisitions. Before VIASYS, Matt was an advisor on mergers and acquisitions, initial public offerings, and commercial transactions in the healthcare field at Morgan, Lewis & Bockius LLP, and a litigator in the health care area at Stradley, Ronon, Stevens & Young.

He holds an AB in Political Science from Princeton University and a JD from Villanova University School of Law.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Real Chemistry

7 followers

Real Chemistry drives the commercial success of healthcare companies by creating AI-powered, idea-driven healthcare experiences with the customer at the center. Over 2,000 experts from a wide range of disciplines collaborate without barriers under a single, unified mission: to transform what healthcare is to what it should be.


Industries

Employees

1,001-5,000

Links